R&D Technology

Partner with us to turn innovation into reality with tech solutions that drive meaningful progress

3 - R&D tech Headers -3 3 - R&D tech Headers -3
Colorized half circle.
R&D Technology Consultant

R&D Technology for Life Sciences

With access to the latest technology and trends, ProPharma’s team of R&D technology consultants takes an integrated approach to determine the best fit-for-purpose technology solutions for our pharmaceutical and biotech clients. We know there is no one-size-fits-all approach when it comes to science and technology, and we customize our service offerings to deliver tailored solutions that are optimized for each client’s unique requirements.

All R&D Technology Solutions

Forward-thinking approaches to life sciences with ProPharma’s R&D Technology solutions and expertise.

 

Digital Transformation Services

Our team of experts provide independent strategic and business consulting services to enable organizations of all sizes to transform their business through better use of technology. We help companies define a digital blueprint and develop a clear, actionable plan to achieve their vision.

Whether you are just getting started on your digital transformation journey or need support with implementation/change management challenges, we are here to help. We have over 25 years of experience across the entire value chain, from early research to manufacturing, including lab systems, manufacturing systems, enterprise systems, data and systems integration, knowledge management and semantic technologies, and data analysis and visualization.

Explore Digital Transformation Services

Research Platforms

Research platforms can take significant time and personnel resources to implement in your environment; and require time-consuming workflow development and requirements gathering. In addition, after your base implementation, your organization will continue to require upgrades, enhancements, and new configurations as your science evolves.

Leveraging an experienced vendor to lead the implementation of each new system as an augment to the existing expertise on your staff can be a beneficial approach. Outsourcing the installation of your research systems provides you with peace of mind, as an expert, with in-depth knowledge of each system, will ensure optimal system configuration for your organization’s specific requirements and use-cases.

ProPharma understands that you have an important job in getting your product to the clinic and eventually to patients. Your technology should enable you to do this more quickly and efficiently. Let our team of experts develop and deliver tailored roadmaps to help you hit your milestones.

There is a range of research systems that can store your data and provide analytics to help you make data-driven decisions about the outcomes of your study. These systems support the lifecycle of your product and are comprised of an array of technologies including:

  • Electronic Lab Notebooks (ELNs)
  • Research Data/Laboratory Data Management Systems (LIMS)
  • Document Management Systems
  • Imaging Platforms
  • Data Warehouse and Analytics
  • Data Visualization and Reporting
  • Bioinformatics & Data Science platforms
  • Machine Learning/Artificial Intelligence Platforms (ML/AI)

Independent Applications Implementation & Configuration

To truly provide value, your research platforms and systems must be configured to firstly, support your organization’s specific workflows, processes, and science; and secondly, to work in unison. ProPharma experts partner with you, taking the time to understand your requirements and needs, and then, in a holistic, software agnostic manner, implement the most optimal solutions accordingly. Backed with best-practice methodologies, as well as laboratory-based research experience, our team of experts will configure and implement each application your organization requires, and then ensure its optimal connection with the rest of your R&D ecosystem.

On–going Support

The evolution and maturation of your science and operations does not stop once your research platform is implemented. Ensuring continual optimization of your systems and configuration of new applications and features can place time and personnel burdens onto an organization, especially if on-staff expertise is absent. ProPharma can provide on-going management services to supplement in this context.

We have established experience developing customized training to support user adoption for platforms such as Benchling and can provide strategic guidance for on-going data governance and new system configurations.

Explore our Benchling Services

Clinical Technology Consulting Services

In addition to understanding technology, our team of experts is well-versed with FDA, European Medicines Agency (EMA), Medicines and Healthcare products Regulatory Agency (MHRA), and Pharmaceuticals and Medical Devices Agency (PMDA) requirements. This expertise enables us to take a holistic approach and optimize your technology stack, aligning both systems and process to organizational goals, and to recommend best-of-breed systems that scale as you grow.

End-to-End Support to Bring Your Platforms In-House

We start with discovery, taking the time to document requirements that align with corporate, technological, and scientific objectives. When desired, we take an active role in system selection, leading the RFP process and scoring vendors and software according to defined selection criteria. Once a system is selected, we conduct implementation and configuration planning and delivery using Agile or Waterfall methodologies. After completing baseline configuration lock, we ensure proper validation and user acceptance testing (UAT), oversee training and change management, and release the system for production in a manner that is honed to encourage successful user adoption. In addition, we offer ongoing managed services with a particular focus on continual process improvement, maximizing new-feature enablement during upgrades and maintaining compliance through effective change control.

strategic-roadmapping

Developing a Strategic Roadmap

Our team of experts can work with you to develop a strategic roadmap, looking at where your organization is today and where it needs to be in the future (typically on a 3-to-5-year time scale). We then develop heatmaps of current state, based on “people, process, and technology” and after looking at technology trends, financial factors including return on investment (ROI) and cost analysis, we craft detailed roadmaps. When appropriate, master data and data flow optimization can be incorporated into the strategic roadmap.

Veeva, Medidata and Other Key Platforms

Managing the wide array of clinical systems required to govern clinical studies can be overwhelming. ProPharma’s technical experts provide guidance and oversight so you can focus on what you do best - bringing new products to market. ProPharma is an official Veeva Service Partner, an Accredited Medidata Partner (Dassault Systemes) and supports numerous technologies such as:


Speak with an Expert

R&D Solutions Consulting Services

We help our clients plan adoption and execution strategies to maximize their technology investments.

Examples of the activities delivered as part of our strategic and business consulting services include:

  • Scientific business analysis and requirements definition
  • Workflow or project prioritization to align with technology adoption
  • Business case development for technology investment
  • Strategy and planning for systems deployment, validation, and operational transition
  • Validation IQ/OQ/PQ services, UAT, and CSV to CSA process adoption

User Requirements Analysis

User requirements are critical to support new investments in software packages or determining if your existing systems are adequate. Our experts can work with your teams to lead you through this process to optimize the most efficient use of your current systems. Well-documented requirements are the key to maximizing your software investments and minimizing costs of deployment and testing prior to end user adoption.

Platform Adoption, Implementation and Deployment

Together with your internal team, we will work to develop platform and system deployment methodologies customized to your corporate objectives. By leveraging our experience, industry best practices, and industry trends, we will create a deployment plan for incremental or phased deployments, developing internal expertise or power users, develop your operational support model, and identify the best-of-breed training and adoption models. Lastly, we will guide you through a streamlined validation practice for any of your systems that fall within regulatory guidelines to ensure compliance.

platform-adoption-implementation-deployment

Technology HealthCheck

Do you have the right platform(s) to effectively carry out your science? Curious about what new technologies are available in the market that provide new capabilities that you may not have? We will review your current platform(s) deployment and identify potential areas for improvement, based on feedback from your users and support teams. We will analyze your operational and governance structure and identify methods to increase user adoption, reduce complexity, and minimize total cost of ownership.

R&D Technology Experts

  • Toby Odenheim Bio Photo

    Toby Odenheim

    Senior Vice President, R&D Technology

  • Matt Dube Bio Photo

    Matt Dube

    President, R&D Technology

  • Warren Vieira Bio Photo

    Warren Vieira

    Senior R&D Technology Manager

    View Bio

  • Sarah Giorgio Bio Photo

    Sarah Giorgio

    Lead Clinical Systems Consultant

Warren is a problem solver by nature, driven to empower others with knowledge, critical thinking ability, and the right tools to be successful. Leveraging a combination IT and scientific knowledge, he leads a team of solution consultants to help organizations manage, structure, and govern their data. Warren has more than 3 years of Benchling experience and is able to support a diversity of use cases using the various Benchling applications.

News & Insights

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

July 28, 2025

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

Learn about PADER, a crucial pharmacovigilance requirement for U.S. drug safety monitoring, and how it differs from PSUR in ensuring compliance and patient safety. Summarizing the main point of the...

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guide for Marketing Authorization Holders (MAHs)

July 25, 2025

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guid...

Learn about the crucial roles of QPPV, LPPV, and PSMF in ensuring effective pharmacovigilance and regulatory compliance for Marketing Authorization Holders (MAHs).

FDA Publishes over 200 Complete Response Letters (CRLs)

July 24, 2025

FDA Publishes over 200 Complete Response Letters (CRLs)

FDA's new transparency with over 200 CRLs empowers sponsors to navigate regulatory challenges more effectively, accelerating drug approvals and enhancing patient access to treatments.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Successfully Executing a Tech Transfer in a Week - ProPharma

July 29, 2025

Successfully Executing a Tech Transfer in a Week

Discover how ProPharma supported a $3B pharmaceutical tech transfer that was executed in just 3 days, relocating five complex product lines. The plan included FDA alignment, pre-approved protocols,...

Case Study Obesity – Accelerated Timelines - ProPharma

July 29, 2025

Obesity – Accelerated Timelines

A mid-size biotech needed fast U.S. market entry for an obesity trial. ProPharma activated 20 sites in 30 days and enrolled 300+ patients—meeting goals despite an increased sample size. Strategic...

Whitepapers Key Compliance Challenges in U.S. Medical Information Services - ProPharma

July 29, 2025

Key Compliance Challenges in U.S. Medical Information Services

For Medical Information (MI) teams navigating today’s evolving regulatory landscape, compliance isn’t just a requirement — it’s a strategic imperative. From managing off-label inquiries to...

Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

July 22, 2025

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand...

MAH Essentials: Ensuring Compliance for European Market Entry

July 10, 2025

MAH Essentials: Ensuring Compliance for European Market Entry

This webinar covers the key responsibilities of Marketing Authorization Applicants/Holders and Qualified Persons in the EEA/UK, including pharmacovigilance requirements, legal entity setup, and...

News & Insights

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

July 28, 2025

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

Learn about PADER, a crucial pharmacovigilance requirement for U.S. drug safety monitoring, and how it differs from PSUR in ensuring compliance and patient safety. Summarizing the main point of the...

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guide for Marketing Authorization Holders (MAHs)

July 25, 2025

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guid...

Learn about the crucial roles of QPPV, LPPV, and PSMF in ensuring effective pharmacovigilance and regulatory compliance for Marketing Authorization Holders (MAHs).

FDA Publishes over 200 Complete Response Letters (CRLs)

July 24, 2025

FDA Publishes over 200 Complete Response Letters (CRLs)

FDA's new transparency with over 200 CRLs empowers sponsors to navigate regulatory challenges more effectively, accelerating drug approvals and enhancing patient access to treatments.

Previous Post Arrow Next Post Arrow
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Successfully Executing a Tech Transfer in a Week - ProPharma

July 29, 2025

Successfully Executing a Tech Transfer in a Week

Discover how ProPharma supported a $3B pharmaceutical tech transfer that was executed in just 3 days, relocating five complex product lines. The plan included FDA alignment, pre-approved protocols,...

Case Study Obesity – Accelerated Timelines - ProPharma

July 29, 2025

Obesity – Accelerated Timelines

A mid-size biotech needed fast U.S. market entry for an obesity trial. ProPharma activated 20 sites in 30 days and enrolled 300+ patients—meeting goals despite an increased sample size. Strategic...

Whitepapers Key Compliance Challenges in U.S. Medical Information Services - ProPharma

July 29, 2025

Key Compliance Challenges in U.S. Medical Information Services

For Medical Information (MI) teams navigating today’s evolving regulatory landscape, compliance isn’t just a requirement — it’s a strategic imperative. From managing off-label inquiries to...

Previous Resource Arrow Next Resource Arrow
Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

July 22, 2025

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand...

MAH Essentials: Ensuring Compliance for European Market Entry

July 10, 2025

MAH Essentials: Ensuring Compliance for European Market Entry

This webinar covers the key responsibilities of Marketing Authorization Applicants/Holders and Qualified Persons in the EEA/UK, including pharmacovigilance requirements, legal entity setup, and...

Previous Webinar Arrow Next Webinar Arrow
Gradient Image

Complex Needs Require Custom Solutions

ProPharma builds solutions at the intersection of innovation and flexibility. We’re here to offer a custom alternative that fits your unique needs. Standout solutions scaled to your size.